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Abstract
Both nanocrystalline silver and bacterial cellulose have been used as
biomedical materials. Silver has been used as an antimicrobial agent, and bacterial
cellulose as a wound dressing. The combination of both these technologies has the
potential to create a synergistic scenario.

A novel method for the attachment of

nanocrystalline silver to bacterial cellulose has been developed.

The cellulose is

oxidized with sodium metaperiodate to dialdehyde cellulose and functionalized with
silver using thiosemicarbazide, silver protienate and ammoniacal silver. The samples
were prepared using both a commercially available bacteria cellulose wound dressing,
Biofill, and lab made, wet pellicle, as the substrate.

The antimicrobial efficacy

against E. coli and S. aureus has been determined using a modified disk diffusion test
procedure, and the release profiles of silver into deionized water were determined.
These tests have shown an antimicrobial efficacy ranging between 1 day for the
Biofill prepared samples and 5 days for the pellicle based samples.

Key Words
Bacterial cellulose, nanocrystalline silver, nanoparticles, wound dressing, disk
diffusion test, silver, cellulose, nanofibers, nanomaterials.
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Chapter 1 - Introduction
"Great things are done by a series of small things brought together."-Vincent Van Gogh

There is no doubt that Van Gogh was considering things more abstract than the
field of material science when he uttered the above words; but, they could now easily be
applied to nanotechnology.

Nanotechnology is the science of bringing together the

smallest of things in an attempt to achieve the very great. A nano-object is commonly
defined as something having dimensions of less than 100 nm, a nanometer being one
billionth of a meter. Nanomaterials are small, so small that it becomes possible and even
reasonable to quantify the number of atoms that they contain. It is this realm that many
researchers are choosing to explore. Nanotechnology has become an expansive field of
research in a short time and has had or will have an impact on many facets of everyday
life, including in the electronic, chemical and biomedical fields.

In the field of biomedical engineering, new materials are sought to improve
medical devices. The wound dressing, possibly one of the first ever biomedical devices,
is now starting to incorporate nanotechnology. Plant derived cellulose, in the form of
cotton gauze, is the most common material used in wound dressings, but now the more
pure bacteria derived cellulose has found a niche in areas where cotton is less than ideal.
Acteobacter xylium, a bacteria, produces a ultra-pure form of cellulose in a non-woven
mesh of nano-fibers.

Bacterial cellulose (BC) has demonstrated several noted

advantages over plant derived cellulose, including immediate pain relief, a close
adhesion to the wound bed, transparency that allows for easy wound inspection, faster
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healing, and improved exudates retention. [1], In addition to an established role in the
field of wound dressings, bacterial cellulose is finding a place in other medical devices,
Millon et al. explored the use of bacterial cellulose as a constituent in a poly(vinyl
alcohol) aorta prosthesis, and others are exploring it as a possible tissue engineering
scaffold [2] [3],

To further improve upon the properties of BC, we have devised a method for
building in an antimicrobial efficacy using nanocrystalline silver. Nanocrystalline silver
as an antimicrobial agent has garnered a lot of attention in recent times with a proven
efficacy against a wide spectrum of infectums, including bacterial, viral, and fungal
pathogens. It has been described as having the following advantages over other topical
antibiotic treatments: it is effective against antibiotic resistant bacteria; it is difficult for
bacteria to develop resistance against it; it has no known major side effects; and it
potentially has anti-inflammatory properties [4],

Research has been conducted on

incorporating it into a wide variety of medical devices, including orthopedic implants,
heart valves, surgical masks, and wound dressings, with varying degrees of success.

This report will examine a novel method for chemically binding nanocrystalline
silver to a bacterial cellulose substrate. The method is comprised of three steps:

1. Selection of the BC substrate
2. Oxidation of the BC substrate
3. Attachment of Ag-NPs to the BC substrate

These steps will be explored and the resulting material will be objectively examined for
possible use as an antimicrobial biomaterial.
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Chapter 2 - Review of Literature
In this chapter a short historical perspective is provided for each of the major
components of this project followed by an in depth exploration of on-going research in
the respective field.

2.1 - Silver nanoparticles
The spread of antibiotic resistant bacteria has become a major concern for
today’s health care professionals. Nosocomial infections have been estimated to cause
over 8000 deaths yearly in Canada [5], and has been described as the fourth most
common cause of death in the United States [6], These incredible statistics have grown
with the increase in antibiotic resistant ‘super bugs’, and have led to widespread use of
alternative forms of infection control. One important alternative to antibiotics is silver.

The use of silver for its antimicrobial properties can be traced through history to
superstitious and anecdotal practices, such as the ancient Romans storing drinking water
in silver containers to prevent the spread of illness [7], or in more recent times to the
coating of washing machines or toilet seats with silver nanoparticles (Ag-NPs) [8],
While the true effectiveness of these practices is questionable, as early as the 17th
century silver nitrate had found an important and somewhat verifiable role in medicine;
it was frequently included in the medical supplies of a ship’s surgeon and used to treat
sores. [9] In the 18th century, it took on a larger role in treating dermal ulcers, and the
next century saw silver nitrate used to treat large burns. Silver nitrate was adopted for
these uses not because of its antimicrobial properties, which were incomprehensible with
the level of a medical knowledge of the time, but as a cauterizing agent to remove
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granulized tissue and promote scab formation. It seems obvious with today’s knowledge
that silver nitrate’s unknown antimicrobial role aided many unwitting physicians and
patients in the treatment of wounds [9], It was not until 1874 that the antimicrobial
properties of silver salts were first investigated, and at this time silver nitrate was used in
the treatment ophthalmianeonatorum, the infection of a newborn’s eyes with gonorrhea.
This treatment is still used today. The use of silver nitrate for the treatment of burns
increased until World War II when instances of its use quickly declined with the advent
of penicillin and other antibiotics. Silver nitrate returned to the medical fray with a
paper published in 1965 by Moyer. [10]

At this time, silver sulphadiazine was

developed “ ...to combine the inhibitory action of silver with the antibacterial effect of
sulphadiazine.” [11] Whether the effects of silver can be described as inhibitory or
antimicrobial will be discussed in the next section.

Accompanying the success of silver salts in fighting infection, there was an
increased interest in using metallic silver in a similar fashion.

Silver has been

incorporated in both urinary and venous catheters, with moderate success [12]. There
have also been attempts to liberate silver ions from metallic silver with novel methods
such as using an electric current. One such study, conducted by Falcoe and Spadaro
show a greater inhibition of bacteria at the anode of a silver coated piece of nylon,
compared to the control [13]. Yet, they fail to discuss the independent effects of an
electrical current on the growth of the bacteria.

The use of metallic silver has been over shadowed by the success of silver
nanoparticles (Ag-NPs).

Ag-NPs are generally held to be particles, sometimes

crystalline in nature, of less than lOOnm in size. The antimicrobial efficacy is inversely
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proportional to size, with smaller particles being more effective [14]. One important
thing to note is while frequently described as ;nanosilver,’ some are composed of a large
percentage of silver oxide, this is due to the large ratio of surface to bulk silver
molecules [15]. Silver oxide has been used as an antimicrobial coating in the past [16],
and the silver oxide component of the nanoparticles could play a significant role in their
antimicrobial efficacy. Djokic and Burrell investigated silver oxide’s role, concluding,
“An essential factor leading to an antimicrobial activity of metallic silver is a presence
of Ag oxide(s) at the surface of this material.” [17]

There are now efforts to incorporate Ag-NPs into a wide range of medical
devices, including but not limited to bone cement [18], surgical instruments [19],
surgical masks [20], and wound dressings; the latter is the primary focus of the research
presented in this thesis. Ag-NPs are considered a significant advancement in wound
care technology, and several large biomedical companies, including Smith and Nephew,
Inc.; Johnson & Johnson Medical Ltd.; ConvaTec ER; Squibb and Sons LLC; Argentum
Medical LLC; Coloplast Ltd.; Medline Industries Inc.; and others have available
products.

In a sort of feedback loop, these biomedical companies have sponsored

additional research into their products, increasing the available literature several fold [8]
[4]. One review article author, after wading through the plethora of research, found it
necessary to remind the reader to remain objective in the face of such a “marketing
blitz.” [21]

2.1.1 - How does silver work?
One important characteristic of the antimicrobial nature of silver is that bacteria
have difficulty developing resistance to it. It has been hypothesized that this is the result
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of ionic silver having multiple modes of lethality, requiring a high level of adaptation in
any given bacteria species [22], These modes of lethality are still being debated in the
literature and are summarized by the following: an uncoupling of the respiratory chain
from oxidative phosphorylation [23]; the collapse of the proton-motive forces across
mitochondrial membranes [24]; a destructive interaction with thiol- groups of membrane
bound enzymes and proteins [25]; and the binding to and seizing-up of DNA replication
machinery.

Ag-NPs act as reservoirs for ionic silver encompassing its modes of

lethality, but additionally it punches holes in the cellular membrane of a bacterium,
essentially causing the cell to bleed to death [26],

In addition to its antimicrobial role, there has been some research conducted on a
potential role for silver compounds as antiviral agents. Silver sulfadiazine has been
investigated as a tool to prevent ocular infection [27] and another silver-sulfur complex
has been investigated as an antiviral coating for consumer products [28]. Ionic silver has
also been investigated as a method to inactivate viruses in drinking water when
combined with UV radiation [29]. More recently, Ag-NPs have been shown to have
antiviral properties too.

In 2005, two studies were published that described the

interaction between Ag-NPs and HIV-1. One study showed that Ag-NPs bind to the
surface of the virus where the glycoproteins essential to the infectious properties of the
virus are assumed to be; this study went on to show an in vitro reduction of infection
with silver treated HIV [30]. Another study showed that apoptosis can be delayed in
human T-cells infected with HIV, by using Ag-NPs to reduce the viral load. [31] The
same study showed Ag-NPs reduced HIV replication.
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Ag-NPs have been portrayed as a wonder drug when it comes to the wound
healing industry, and in addition to the widely published and accepted antimicrobial
ability of Ag-NPs, there has been some published work on other wound healing benefits.
One study shows that Ag-NPs decrease inflammation, decrease cell death and reduce the
concentration of harmful enzymes in the wound [32], While inflammation is the body’s
way of clearing tissue debris, fighting infection and triggering the growth of new tissue;
in a

properly

treated

wound,

a prolonged

inflammation

response

can

be

counterproductive. Several papers report that Ag-NPs can either diminish inflammation
or the results of it. Wright et al. states that Ag-NPs can “...play a role in altering or
compressing the inflammatory events in wounds and facilitating early phases of wound
healing.” [32] Shin et al. shows that Ag-NPs can alter cytokine production in human
cells in vitro, and suggests it could be used as a treatment for inflammatory diseases
[33], This is further confirmed in a porcine model by Nadworny et al [34]. It should be
noted that most of this research has been conducted by groups with a vested interest in
their silver systems.

There are aspects of Ag-NPs that are debated in the literature, such as the effect
on the rate of reepithelialisation. One study suggests that Ag-NPs increase the rate of
reepithelialisation by up to 70% [35], while another suggests it delays reepithelialisation
by over 50% [36]. These conflicting results are not limited to those two studies, Honari
et al. also shows improved healing at skin graft donor sites [37], where as Vlachou et al.
says delayed healing is experienced [38] when a Ag-NP dressing is used. These counter
claims emphasize the on going debate in the literature about the effects of Ag-NPs
dressings. One point that is not contended is that Ag-NP dressings can be left on the
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wound for a period of up to seven days, whereas silver nitrate and silver sulphadiazine
need to be reapplied every 2 and 12 hours respectively. Conventional wisdom is that the
less disturbed a wound is during the healing process the better.
2.1.2 - Methods use for creating Ag-NPs
There are many different procedural pathways that can produce Ag-NPs. They
can be divided into three broad categories; physical vapor deposition, ion implantation,
or wet chemistry.

Figure 2.1: Acticoat - three layers exposed.

Acticoat is widely accepted as the gold standard of Ag-NP wound dressings; and
is a good example a silver system prepared by a physical vapor deposition process. In
the case of Acticoat, the physical vapor deposition process involves placing the substrate
(in this case HDPE) in a chamber opposite a silver cathode. The chamber is filled with
argon gas; a current is passed through the gas, driving argon atoms into the silver
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cathode knocking free some silver atoms. The silver atoms are deposited in nanoparticle
form on the substrate [39]. Several other researchers have also used physical vapor
deposition to create silver particles [40] [41] [42], The particles created in this manner
generally have been shown to be crystalline with crystallite grain diameters of
approximately 15 nm [15]. A photo of a sample of Acticoat can be seen in Figure 2.1,
Scanning Electon Micrographs are presented and discussed in the Results and
Discussion chapter.
Although it may seem counter-intuitive, ion-implantation has been used to create
Ag-NPs [43] [44], This process has been shown to produce silver particles embedded in
polyurethane, silicone, polyethylene, and polymethylmethacrylate [45] [46].
particles grow in the substrate with the bombardment of ions.

The

The existence of

nanoparticles is proven with optical absorbance, and the exact nature of the particles
created with this method is not known.
There are several wet chemistry methods for creating silver nanoparticles,
including the use of a reducing agent like sodium borohydride (NaBH4).

Sodium

borohydride has been used with polyvinyl alcohol [47], poly(vinylpyrrolidone), bovine
serum albium [30], citrate [48] [49] and cellulose as stabilizing agents. In the case of
BSA, the sulfur-, oxygen- and nitrogen-bearing groups mitigate the high surface energy
of the nanoparticles during the reduction [30]. Whereas the hydroxyl groups on the
cellulose are reported to help stabilize the particles. Citrate and cellulose have been used
to create Ag-NPs independent of a reducing agent as well. An additional novel wet
chemistry method used to create Ag-NPs took advantage of B-D-glucose as a reducing
sugar and a starch as the stabilizer. [50]
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In addition to the methods of nanoparticle formation discussed in this section, it
should not be interpreted as an exhaustive list; there are alternative pathways for creating
Ag-NPs, but they are relatively uninvestigated [51] [52] [53]. Also, it is important to
note, not all nanoparticles are created equal. The size and shape have been shown to
have an impact on its efficacy [22], Additionally, crystal facet size, oxide content and
several other factors could also affect the antimicrobial properties [4].

2.1.3 - Potential health concerns with nanosilver
Ionic silver has had a long history of use in medical applications, and it has been
shown irrefutably that ionic silver, in the right quantities, has a net positive benefit in
treating wounds. Ag-NPs do not have such a long pedigree; and although over the last
ten years it seems to evidently be an effective agent, it would be irresponsible to look at
any relatively new technology without considering the potential problems.

First, it is best to dispel two common misconceptions about the safety of a topical AgNP dressing.
Allergic Reaction: While there is anecdotal evidence suggesting the possibility
of a silver allergy, an extensive review of the medical literature does not lend any
credence to this possibility [54], Some silver alloys that include nickel do elicit
an allergic reaction, but those alloys are outside the scope of this thesis.

Argyria and Staining:

Ingested silver compounds, like colloidal silver, can

cause a condition called argyria, which is manifested as a permanent bluish-grey
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hue. A systemic change in colour is not a possible contradiction with the topical
application of silver. The only reference to such an outcome in the literature is a
case study of a 17-year-old man, who sustained burns to 30% of his body, and
experienced a temporary bluish-grey hue after several days of treatment with
Acticoat [55]. Argyria is the deposition of silver in deep tissues, a condition that
cannot happen on a temporary basis, raising the question of whether the cause of
the man’s discoloration was argyria or even a result of the silver treatment [56].
Silver dressings are known to cause a ‘‘transient discoloration,” that dissipates in
2-14 days, but not a permanent discoloration [57].

To properly evaluate the safety of the topical application of silver, three criteria
must be examined; how much of the silver is absorbed; what is its effect; and what is its
longevity in the body [58], Normal levels of silver in blood plasma are below .0005
ug/mL, and levels of up to

.440 ug/mL have been observed as the result of the

application of silver sulfadiazine cream, without any adverse side effects [59], Although
silver levels o f . 193 ug/ml in blood plasma for a sustained period (three weeks) has been
suggested as the cause of renal failure and death in one case study [60]. After
discontinuing a silver treatment, silver blood plasma levels remain elevated for
approximately three weeks before returning to normal. Silver is cleared through the
urine, and some caution is required when treating a patient with poor kidney function, as
they are likely to maintain a high blood silver concentration. [61]. A study conducted in
vitro showed ionic silver levels of 13 to 56 ug/mL were toxic to human fibroblasts, the
authors suggests the mechanism for toxicity was the same as heavy metal toxicity [62],
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Most papers that discuss the health implications of topical silver application conclude it
is a safe and effective treatment [62].

Ag-NPs have different characteristics than ionic silver and are potentially
tolerated differently. One point of contention in the literature is how readily Ag-NPs
from a wound dressing can penetrate the skin.

It has been observed that Ti02

microparticles found in sun-block creams can penetrate to the dermis [63], but there is
no direct evidence suggesting that silver levels increase in the blood when Ag-NPs are
applied to intact skin []. Rarely however, are these dressings used on intact skin, and it
is important to evaluate the dressings in real world scenarios: on compromised skin. An
increase in blood silver levels has been observed after the application of a Ag-NPs
dressing; in a study with 30 burn patients, a maximum silver blood plasma level of .230
ug/ml was observed, with a mean of .074 ug/ml at the end of treatment [38]. The
authors suggest that the higher blood silver levels were related to kidney function affecting silver clearance. No statistically relevant liver toxicity was observed in this
study.

Paknikar et al. have investigated the effect of 7-20 nm Ag-NPs on human
fibrosarcoma (HT-1080) and human skin/carcinoma cells (A431) [65],

They found

levels of .78 to 6.25 ug/ml for the human fibrosarcoma cells and 1.56 to 6.25 ug/ml in
the human skin/carcinoma cells initiated apoptosis; whereas levels of 12.5 ug/ml caused
necrosis in both.

In an in vivo (rats) study conducted to determine the systematic

toxicity of Ag-NPs 60nm in size, found induced liver toxicity and coagulation in
peripheral blood, at the end a 28 days of oral administration [66], To summarize, the
potential health implications, of using Ag-NPs: blood plasma levels do not reach a level
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of anywhere near concern with standard usage of Ag-NP dressings. If they do reach
dangerous levels, one would look at the liver and the kidneys to observe the effects.
Additionally, with silver being cleared through the kidneys, caution should be taken
when considering the use on a patient with impaired kidney function.

No discussion of the health impact of silver would be complete without a review
of the St. Jude’s Silzone heart valve - a significantly notable event in the medical device
industry. The Silzone valve was a standard bileaflet mechanical heart valve that was
complemented with a silver coated Dacron sewing cuff [67].

Figure 2.2 shows an

example of such a heart valve. While the nature of the silver coating on the cuff was not
discussed in the literature, it was applied using a technique of ion beam-assisted
deposition [68] suggesting it could be in the form of Ag-NPs. The silver was included in
an attempt to decrease instances of endocarditis, an infection of the valve annulus. The
valve was approved for sale in Canada, Europe, the United States, and most other
markets around the world. In a post-commercialization study, researches showed that
the valve prevented tissue ingrowth, created paravalvular leakage, valve loosening, and
in the worst cases the valves have to explanted. After 3 years on the market and 36 000
implants, St. Jude discontinued and voluntarily recalled the valve [69], This detrimental
effect of silver has not been observed in the case of wound dressings - with the
exceptions

of the

reepithelialisation.

previously

discussed

conflicting

reports

on the

rate

of
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Figure 2.2: St. Jude Heart Valve

2.1.4-Su m m ary

As discussed in this section, silver is an exceptionally useful antimicrobial agent,
with a long history of use in medical applications. Ag-NPs are a more recent
development, but share the positive attributes of silver salts, and also have limited
drawbacks. The implantation of Ag-NP materials would raise concern in the medical
community, given the failure of the Silzone heart valve, but the topical application of
Ag-NPs in the form of a wound dressing has been proven safe and effective. The only
thing lacking is a controlled method for delivering silver to the wound environment to
both create a sustained antimicrobial effect and decrease the potential for discoloration.
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2.2 - Bacterial Cellulose
Cellulose is the most prevalent polysaccharide in nature.

There is a global

annual production of approximately 1.5 trillion tons, primarily found in the woody
structure of plants [70], BC has the same 13-1,4-glucan chemical structure shown in
Figure 2.3, but is produced in an ultrapure form without the lignin and hemicellulose
found mixed with plant sources of cellulose. It also has a different morphology and
different physical properties. Plant cellulose has a degree of polymerization of 13000 14000 where as BC has a degree of polymerization of 2000 - 6000. Depending on
culture conditions BC can be produced in a less structured non-woven mesh-like form or
in a freely suspended fiber form, with fiber bundles having a diameter of approximately
50 nm (although this too can be a function of culture conditions). BC has a great affinity
for water, with water content of up to 99% by mass. The loss of this water during drying
results in an irreversible structural change due to loss of the hydrogen bonds; this will be
discussed further in Chapter 4 [70].

Figure 2.3: Chemical ¡structure of cellulose

Although, there are a few genera of bacteria that produce cellulose including
Acetobacter, Rhizobium, Agrobacterium and Sarcina, the species that has garnered the
most attention is Acetobacter xylium (also known as Gluconacetobacter xyliuns) [71].
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A. xylium is a gram-negative, rod shaped aerobic bacterium with a long history of
cultivation. Originally used for vinegar production, it is relatively easy to culture and
has a high yield of cellulose; both factors that make it a prime research and
commercialization target.

Plant cellulose was first described by Anselm Payen in 1838, who determined its
chemical composition by way of elemental analysis.

While BC has been used for

hundreds of years in the traditional Philippine dessert nata-de-coco - a BC pellicle
soaked in syrup - it was first confirmed as cellulose in 1886 by AJ Brown [72],

The focus of the original research into A. xylinum and BC followed two avenues.
First, it was used as a vehicle to examine the biochemical pathways of cellulose
production, research that could be used to model cellulose metabolism in higher
organisms [72]; and second, for the commercial application of paper production - a
primary use of plant cellulose [73]. The original hope was that BC could become a
substitute for plant-derived cellulose in the paper making process, but the relatively high
production costs have prevented BC from becoming widely used. It has however found
a niche role in some higher-grade papers, as a finishing layer. In the patent databases,
one can find reference to a wide range of potential BC applications, as a food thickener;
as a film to maintain the moisture of chewing gum; as a coating to slow the burning of a
cigarette; and as a rheological modifier for use in drilling mud formulations [74],
Despite the ingenuity for finding potential applications, only three have met with
success:

nata-de-coco (the previously mentioned Philippine dessert); as an acoustic

membrane in high-end Sony earphones [75], and as a wound dressing [1],
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One continuing mystery surrounding BC is its exact biological function. A.
xyliam is a successful and prevalent bacterium in nature, frequently finding a home in
rotting fruits and sweetened liquids. The most familiar form of BC is that of a pellicle
on the top of a static cultured growth media. It has thus been hypothesized that cellulose
acts as a floatation device bringing the bacteria to the oxygen rich air-media interface.
This hypothesis has largely been discredited by experiments conducted on submerged
oxygen-permeable silicone tubes that show cellulose grows well submerged if enough
oxygen is present [76]. Others suspect that cellulose is used to immobilize the bacteria
in an attempt to keep it near the food source; or as a form of protection against
ultraviolet light [77].

Cellulose I

Figure 2.4: Cellulose synthesis redrawn from |78|.

BC is assembled extra-cellularly. Cellulose monomers are synthesized by the
enzyme, cellulose synthase, within the cell and are excreted from two rows of 50 to 80
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pores in the cell membrane, where they form protofibrils of between 2 - 4 nm. These in
turn are bundled into fibrils of 80 nm by 4 nm, which are assembled in fiber form.
Figure 2.4 shows this in detail, with the protofibrils being secreted from the pores in the
membrane and being assembled into larger fibers. These fibers are considered cellulose
type I, whereas cellulose type II fibers are B-1,4 glucan chains arranged in disorganized
and random manner. The fibers have been described as morphologically falling between
algal and plant cellulose [79], An interesting occurrence with BC is the division of the
fiber with cell division - the fiber branches into two as the cell divides and the fiber
forming apparatus is divided as well [80].
2.2.1 - Production of cellulose
BC can be produced in either static or agitated cultures. In static culture, the
cellulose is produced in a nonwoven nano-mesh that grows on top of the media - a
pellicle. Static culture has been successfully used in commercial applications, where a
sheet of cellulose is required, such as in a wound dressing, audio diaphragm or in the
case of nata-du-coco. Agitated culture produces cellulose in a loose fiber suspension, or
in the irregular balls of loosely related fibers. Agitated cultures have a few hypothetical
advantages for bulk bacterial cellulose production: it requires less space, is less labour
intensive, and is more cost effective; these benefits have yet to be commercially realized
[81] [82], Other culture methods have been attempted with moderate success, including
an air-lift reactor and a continuous static culture bioreactor which pulls the pellicle from
the surface of the media at a rate equal to its growth [83], Additionally, shake flask
cultures are frequently used to produce BC in smaller quantities for research purposes.
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There is a wide range of medias used for the production of BC. The traditional
nata-de-coco cottage

industry uses coconut milk mixed with sucrose, with

approximately a fifth of the media coming from the left-overs of the last batch. The
coconut milk can be substituted for other fruit juices like pineapple juice, to create
desserts like nata-de-pina [84], One frequently used research media is Schramm and
Hestrin Medium [85], Developed by Schramm and Hestrin and described in a 1954
paper, it includes (% w/v): glucose, 2.0; peptone, .5; yeast extract, .5; disodium
phosphate, .27; citric acid, .115. The pH of the media is adjusted to a pH of 6.0 with
diluted HC1 and NaOH [86]. There are many variations on this basic media description,
but all iterations contain a carbon source whether it is in the form of glucose, fructose,
sucrose, monosaccharides, or unrefined sugar sources like fruit juice, or beet molasses
[87]. They also must have a nitrogen source, this is the yeast extract in the case of the
Schramm and Hestrin media, but could be corn steep liquor, or an synthetic form a
nitrogen.

Researchers have used a wide variety of media additives, from antifoam in
shaken and agitated cultures, to a wide variety of vitamins including: inositol, nicotinic
acid, pyridoxine hydrochloride, thiamnine hydrochloride, D-pantothenic acid calcium,
riboflavin, p-aminobenzoic acid, folic acid and d-biotin [88], Thickeners have been used
to allow for higher agitation speed, while lessening the effects of shear. These include
xanthan, agar, acetan, polyacrylamide-co-acrylic acid and alginate. In one such case, the
addition of 0.4% (w/v) agar to the media was shown to enhanced the production rate of
cellulose by over 50% [88], Polyacrylamide-co-acrylic acid was shown by Joseph et al.
to have a similar effect by more than doubling BC production from 2.7±.8 to 6.5±.5 g
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dm° [89] Others have learned that the addition of alginate prevents cellulose clump
formation increasing cellulose yield [90].

Ethanol has also been added to culture

medium, with mixed results. One group showed that ethanol reduced the production of
gluconicacis, lowering pH levels to sub-optimal levels; [91] while others have reported
an increased yield in instances where ethanol is added. [92]

In relation to additives there are several other culture conditions that affect BC
production and yields. These include: pH, temperature, dissolved oxygen, and shear
rate. The optimal pH for BC growth has been described as falling within 5-7 or 4-6,
with most research papers reporting using 5. A. xylium produced gluconic acid, which
lowers the pH requiring a pH control system to maintain the ideal level [93]. Frequently
4N NaOH and 4 N H2S04 are used to control pH [8 8 ]. Dissolved oxygen is usually
maintained at 30%. [8 8 ], A temperature range of 25-30 degrees Celsius is described as
the optimal temperature range, but the narrower range of 28-30 degrees Celsius is
usually used.
One potential method of increasing the cellulose yield is through co-culture.
Seto et al. in attempting to isolate a culture of A xylium discovered a colony of A xylium
growing in close association with Lactobacillus mali [94],

It was found that when

cultured together the cellulose yield was tripled. The researchers could not sufficiently
explain the increased yield; they eliminated the possibility of a direct role for
extracellular polysaccharide produced by L. mali, and did not observe any active
extracellular enzymatic activity. Regardless, the increased cellulose production is an
interesting observation.
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2.2.2 - Bacterial cellulose as a wound dressing
It is difficult to know for certain what the first medical interventions were in
human history, but to hypothesize that it was the covering of a wound - would be a good
guess. The dressing of a wound is essential for the health of a patient; infection can
threaten anyone regardless of wound size if left unsterilized and exposed; fluid loss can
kill those with extensive burns; and, dermal ulcers can threaten both life and limb.
Cosmetically, the covering of a wound can reduce scarring. The characteristics that
make an ideal dressing include biocompatibility, sterility, semiocclusiveness, strength,
conformability, and moisture retentive properties [95].

While wound dressing

technologies based on materials such as alginate or synthetic polymers go part way
towards addressing the required characteristics, BC does a better job.

BC has a wound care pedigree, being chemically identical to cotton - which in
the form of cotton gauze has been an essential dressing material. BC, like cotton gauze,
is highly biocompatible. Research conducted at Chalmers University of Technology in
Goteborg Sweden has confirmed this [96].

With the intent of developing a tissue

engineering scaffold, the group conducted systematic biocompatibility studies by
placing pieces of BC subcutaneously in a rat model. The group observed no signs of
inflammation or other symptoms of a negative host response. The group has continued
to pursue their tissue engineering scaffold, and have found BC performs favorably with
both smooth muscle and endothelia cells [3], As of late 2006, this group is testing their
tissue engineered BC small diameter vessels in a large animal model.

Bacterial cellulose, like Ag-NPs, can be used to treat dermal ulcers and burns.
Dermal ulcers are notoriously difficult to cure even after the underlining pathology is
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treated. A dermal ulcer is usually defined as a wound which has a loss of integrity, is
infected, and has difficulty healing; with treatment they can take weeks or months to
heal and in severe cases require radical intervention like amputation. Alvarez et al.
tested Xcell, a dressing based on wet BC pellicle, in the treatment of venous leg ulcers,
and found considerable improvement over the standard treatment [97]. The two areas of
greatest improvement were in: autolyic debridement, with a 40% increase in the removal
of nonviable tissue; and pain, with a statistical significant reduction in reported pain.
Alvarez et al. stated that the BC dressing “...creates a protective, hypoxic, moist
environment similar to an undisturbed wound protected by its own blister roof.”

In addition to the treatment of ulcers, studies conducted on using BC in the
treatment of burns have been promising. Legeza et al. studied the impact of bacterial
cellulose on radiation and thermal burns and showed that a BC dressing accelerated
wound healing by between

6

and 17 %, with scab detachment occurring 14-15% sooner

[98]. Apart from the commercially available products, Czaja et al. have investigated
using a never-dried bacterial cellulose membrane for the treatment of 2nd and 3rd degree
burns in animal models [1]. They were found to accelerate the healing process. He also
listed the additional benefit of being able to produce sheets of a variety of sizes,
therefore eliminating the need to staple together several smaller sheets, as is standard
procedure with other wound dressings.
The commercialization of BC wound care products has proceed in an anfractuous
manner, with Johnson and Johnson conducting the original research into a bacterial
cellulose wound care system in the 1980s, but not actually producing a marketable
product [99] [100], Johnson and Johnson later sold their bacterial cellulose technology

23

to Xylos Corp.

Xylos produced a BC dressing under the trade name XCell.

The

company continued research into the biomedical applications of BC filing patents on a
bacterial cellulose wound dressing customized for chronic wounds and for an
implantable soft tissue repair graft [101]. But, Xylos Corp sold their cellulose wound
care line to Lohmann and Rauscher GmbH, a company much better suited to the
marketing and delivery of the product.

Bionext Produtos Biotechnologicos Ltda, a

Brazilian company, developed their own line of wound care products independent of
Johnson and Johnson’s original research. Bionext’s first generation product was called
Biofill, but has since been replaced by a next generational product called Bionext [102],
While the only commercialized medical applications of BC are in the field of wound
care there is continued research into other uses. These include skin tissue engineering
[103], cartilage tissue engineering [104], small diameter blood vessel replacements
[105], and as a brain dura substitute [106],
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Chapter 3 - Experimental Methods
3.1 - Bacterial cellulose production
Two types of bacterial cellulose were used to conduct experiments: dried pellicle
in the form of the commercial product Biofdl and lab-made, wet pellicle.

Biofill,

obtained via Axcellon Inc. from Bionext Produtos Biotechnologicos Ltda., is a dried and
stretched BC pellicle. The lab-made cellulose pellicle was produced using the following
procedure and was preserved in its wet form through all chemical reactions, and dried
prior to characterization and testing.
The BC prepared in the lab was grown from Acetobacter xylinum BPR2001
subsp. Sucrofermentans: American Type Culture Collection (ATCC) number 700178. A
500mL shake flask fdled with 250mL of the media with composition listed in Table 3.1,
was inoculated with three loops of A. xylinum. The shake flask was placed in a shaker
incubator at 28 degree Celsius and 175 RPM for three days. A 10 mL aliquot of this
culture was added to a Pyrex dish measuring 26 by 36 cm and filled to a depth of

8

millimeters, with 750 mL the media listed in Table 3.1. The dish was covered with
tinfoil and placed in a static incubator for 7 days.
Table 3*1: Media Composition

Yeast Extract
Fructose
Potassium Dihydrogenphosphate
Ammonium Sulphate
Magnesium Sulphate
Trisodium Citrate
Citric Acid

(%w/v)
5.3
4
.33
.1
.025
.042
.8 8
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3.1.1 - Cleaning of bacterial cellulose pellicle
The pellicle was removed from the surface of the media as seen in Figure 3.1. It
was rinsed thoroughly in deionised water for 5 minutes. It was then placed into a clean
Pyrex pan, and autoclaved for 15 minutes. It was rinsed again, and placed in 500mL of
1 N sodium hydroxide (NaOH). The BC and NaOH were maintained at 80 °C for 90
minutes, removed and rinsed thoroughly. It was soaked over night and rinsed repeatedly
until all colour was removed from it and its pH was neutral.

Figure 3.1: Pellicle from Static Culture
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3 .2 - Silver Loading
3.2.1 - Dry bacterial cellulose pellicle
The procedure was adapted from Guhados [107] . A sheet of Biofill with a mass
50 mg was placed in 50 mL of .16 M sodium metaperiodate (NalCL) solution, to achieve
a molar ratio of 1:13, cellulose to NalCL. The cellulose and solution were left at room
temperature for 15, 30 or 60 minutes. The cellulose was then rinsed once in ethylene
glycol, to arrest the oxidation, and then rinsed 10 times in deionised water.

The

cellulose was then placed in a solution of 1 % thiosemicarbazide and 5 % acetic acid,
and reacted for 90 minutes at 60 °C. It was then thoroughly rinsed in deionized water
was placed in a solution of 1 % silver proteinate and

2

% sodium borate (Na2 B40 y

•1OH2 O) for 1 hour in the dark. The silver proteinate solution was prepared by mixing
the two constituents and filtering the resulting mixture through a 45 um cellulose-nitrate
filter. An ammoniacal silver solution was prepared by adding 1 gram of silver nitrate
(AgNC>3 ) to

8

mL of deionised water and then adding ammonia hydroxide drop wise

until the brown precipitate dissolved. This solution was diluted to a volume of 75 mLs.
The cellulose was placed in the ammoniacal silver solution and was maintained at 60 °C
for 15 minutes. The cellulose was then rinsed and dried in a convection oven at 23 °C.

3.2.2 - Lab made, wet pellicle
The dry mass of a lab-made pellicle was determined by cutting a section of
approximately 2 cm of wet pellicle, weighing it and drying it at 60° C in a convection
oven. This was done in triplicate.
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A piece of wet pellicle was cut to a size that corresponded to a dry mass of 50
mg and was placed in 100 mL of sodium metaperiodate (NaI04) solution, so a molar
ratio of .5:1, 1:1, 1.5:1, or 2:1 - N aI04:cellulose was achieved . The cellulose and
solution were left at room temperature for 24 hours. The cellulose was then rinsed once
in ethylene glycol, to arrest the oxidation, and then rinsed in deionised water and soaked
for 72 hours. The cellulose was then placed in a solution of 1 % thiosemicarbazide and
5 % acetic acid, and reacted for 90 minutes at 60 °C. The cellulose was thoroughly
rinsed and soaked for 72 hours. The samples was placed in a solution of 1% silver
proteinate and 2% Na2 B4 0 7

IOH2 O. The solution was prepared by mixing the two

constituents and filtering the resulting solution through a 45 pm cellulose nitrate filter.
An ammoniacal silver solution was prepared by adding 1 gram of AgNOi to

8

mL of

deionised water and then adding ammonia hydroxide drop wise until the brown
precipitate dissolved. This solution was diluted to a volume of 75 mLs. The cellulose
was placed in the ammoniacal silver solution and was maintained at 60 °C for 15
minutes. The cellulose was then rinsed and dried in a convection oven at 23 °C.

3.2.3 - Determination of aldehyde groups
The aldehyde group analysis was conducted on pieces of BC taken through the
oxidation step, but prior to the addition of thiosemicarbazide. The cellulose was dried
and weighed. The BC was cut into thin strips, and placed in 10 mL of .05 M sodium
hydroxide (NaOH). It was kept at 60°C for 30 minutes, at which point 5 mL of .1 M
hydrochloric acid (HC1) was added to neutralize the NaOH. The solution was then
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titrated with .01 M NaOH, using phenolphthalein as an indicator [108], Tests were
repeated in triplicate.
3.2.4 - Determination of silver loading
A piece of silver loaded BC with a mass of 20 mg was placed in vials filled 5 mL
solution of 50% nitric acid. The solution was left for 24 hours. The silver concentration
in the samples was measured by a Varian Spectr AA 55, Atomic Absorption
Spectrometer (AAS). Some vials were diluted prior to measuring the concentration, to
ensure the concentration of silver fell within the range detectable by the AAS. The AAS
was preformed at a wavelength of 338.3 nm, using air and acetylene gas for the flame.
The spectrometer was calibrated with .2, .5, 1, 5, 10, 15 ppm of silver standards; the
standards were measured before after sampling to ensure measurement stability. Tests
were repeated in triplicate.

Silver levels were computed using the following equation (1):

S ilver Fraction =

(5 m l + d i l u t i o n v o l u m e ) * m a s s f a c t o r * a b s o r b a n c e * c a l i b r a t i o n f a c t o r
m a s s o f sa m p le

(i)

29

3.3 - Characterization
3.3.1 - X-ray diffraction
AgNP-BC samples were characterized using a Rigaku MiniFlex X-ray
diffractometer. Samples were scanned at a 20 range of 10° to 90° at 0.1° increments.
The samples were stored at room temperature in the dark prior to scanning.

3.3.2 - Scanning electron microscopy
The scanning electron microscopy (SEM) was conducted on a Leo-1530
Scanning Electron Microscope with an accelerated voltage of 1 kV. No coatings were
used. Particle size was determined using ImageJ software. A sample for 500 particles
were measured, 50 per SEM image over 10 SEM images.

3.3.4 - Fourier-transform infrared spectroscopy
The FT-IR spectra of BC and dialdehyde-BC were determined using
PerkinElmer FTIR Spectrum BX. A resolution of 2.0 cm' 1 was used with an interval of
0.5 cm '1, over an interval of 64 scans. The BC sample tested was Biofill, using the
preparation conditions as stated early in the chapter for Biofill, with the exception that
the Biofill was oxidized for 24 hours, as opposed to 60 minutes.
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3.4 - Determination of silver release kinetics
Amber glass vials were filled with 5 mL of deionized water, and BC-silver
samples of sizes shown in Table 3.2 were placed in the water and maintained at 37 0 C.
The samples were transferred to a new vial at 5 minutes, 20 minutes, 40 minutes, 1 hour,
2 hours, 4 hours,

8

hours, 24 hours, 48 hours, and 96 hours. Once the sample had been

transferred to a new vial, the old vial containing the water and released silver was stored
at 4°C, until the silver concentration was measured using AAS. The fractional release of
silver was also determined using equation (1) seen on page 28. Tests were repeated in
triplicate.
Table 3.2: Release kinetic sample sizes

Sample Type
Acticoat
Silver enhanced Biofill
Silver enhanced pellicle

Sample mass in mg
80
30
40

3 .5 - Antimicrobial tests
The antimicrobial protocol used was a modified Kirby Bauer Method; adapted
from Taylor et al. and Clinical and Laboratory Standard Institute’s procedures [4] [109],
Escherichia coli and Staphylococcus aureus Newman were cultured in Trypic Soy Broth
for 24 hours.

The culture was diluted to an approximate cell density of 1.5 *108,

determined by measuring an optical absorbance of 0.132 at 600 nm [109], In 100 pL
aliquots, the bacteria was then placed on Mueller Hinton agar plates and spread using a
cell spreader. Three disks, 1 cm in diameter, of the prepared cellulose film were placed
on the agar in an arrangement that would prevent any overlap of potential clear zones.
The plates were incubated for 24 hours at 35 °C. The clear zones were measured by
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scanning the plates and using the image processing software “Image J.” New agar plates
were then inoculated using the same procedure and the samples were transferred to the
new plates. This process was repeated every 24 hours, until no clear zone remained [4].
The clear zone diameter was measured as seen in Figure 3.2 and the zone of inhibition
was determined using equation 2 :

Zone Diameter

Figure 3.2: How the clear zone size is
determined
„

r i i

•i

•. •

Zone D iam eter-Sam ple D iam eter

Zone o f Inhibition = ----------------- -— ------------Sample Diameter = 1 cm
An example of a plate is seen in Figure 3.3.

Figure 3.3: An example of a clcarzone test on a sample of
silver loaded BC. Tested against S . A u re u s

(2)
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Chapter 4 - Results and Discussion
The primary purpose of this research project is to explore a novel antimicrobial
material for possible use in biomedical applications - with wound dressing being the
area of chief consideration. The design requirements considered while evaluating the
material are the ability to tune the silver loading, maintain the release of silver overtime,
and exhibit antimicrobial properties.

The material is a BC substrate with Ag-NPs

attached to it. It is created in a three-step process (as detailed in the Methods chapter).
The first step is the selection and/or production of the BC substrate. Biofill, a dried and
stretch BC pellicle, was one of two sources of cellulose that was used; it has a successful
commercial history, and the quickest path to making available a silver loaded BC wound
dressing is to predicate it on an already successful product.

The second form of

cellulose used was produced in the lab; this, as we will see is morphologically different
from Biofill, and has correspondingly different characteristics. The second step is the
oxidation of the BC substrate; this step prepares the sample for functionalization with
thiosemicarbazide and silver. And it follows, that the last step is the functionalization or
attachment of Ag-NPs to the BC substrate.

Results of these steps, and their

corresponding characterization will be detailed and discussed in this chapter.
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4.1 - Bacterial cellulose substrate

Figure 4.1: Labmadc cellulose (left) versus Biofill (right). Top and side views.

A piece of lab made, wet pellicle versus Biofill can be seen in Figure 4.1. The
wet pellicle, as produced by the procedure listed in the Methods chapter is comprised of
99% water by mass, with only the remaining 1% being cellulose. When wet it is 2 -3
mm thick, but decreases to a thickness of 60 ±

10

pm upon drying (the other dimensions

remain unchanged), and does not reswell upon rewetting; whereas, Biofill is 40 ± 10 pm
regardless of whether it is dry or wet. The nanostructure of wet pellicle can be seen in
Figure 4.3.

This SEM was taken using critical point drying to preserve the

nanostructure. The highly porous 3-D structure is irreversibly lost during the normal air
drying process; one can note the flattening of the fibers and the collapse of the pores,
due to the loss of hydrogen bonds and their role in preserving the nanostructure, as
illustrated by the SEM of Biofill [110].
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Figure 4.3: Lab made pellicle after critical point dry in g.
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4.1.1 - Production of lab made, wet pellicle

The original work conducted by Guhados on the BC silver material, was
preformed on free BC fibers produced in agitated culture that had been cast into a film
and dried [107], This process is labour intensive, primarily due to the fiber purification
steps required when producing BC in agitated culture, and costly, due to the use of
membrane filters in the casting process. Additionally, the cast film did not share all the
advantageous characteristics of BC pellicle. In response to the issues with using a film
cast from free BC fiber, BC pellicle was selected as the substrate instead. And as
previously stated two types of pellicle were tested: Biofill and lab made, wet pellicle.
An interesting aspect of the wet pellicle was the variation in the produced
pellicle. Like any biosystem there is some variation outside the influence of reasonable
experimental control. For example, the pellicle can partially sink after some initial
growth, allowing for a second thinner pellicle to form; this creates a delaminated or
double-layered pellicle. Also, the smoothness of the pellicle can vary; with some
pellicles bumps of approximately half-a-centimeter in diameter and height were
observed. This occurred in approximately 20 - 25 % of cultures, and could be the result
of mutation of the bacteria.

Mutations in A. xylium are reported throughout the

literature, but primarily manifest as non-cellulose producing phenotypes that arise in
agitated and shaken culture.

One paper reports that these non-cellulose producing

strains often return to producing cellulose when placed back in static culture [111]. It is
unclear what is exactly occurring with the unsmooth BC pellicle, but it could be the
result of mutation in the seed culture - produced in shaken culture - and the return of
those bacteria to cellulose producing pheonotypes once placed in static culture. From a
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pragmatic point of view, this problem was overcome qualitatively, with some pellicles
being rejected on personal judgment, like in any quality control inspection.
A growth period of 7 days was selected as the pellicle had an area density, when
dried, similar to Biofill. While Biofill is described as being dried and stretched, the lab
made pellicle was not stretched, as the exact procedure for doing this is not known and it
is suspected that specialized equipment is used. So, while Biofill and lab made pellicle
share a similar area density, they are not necessarily identical.
If grown for a long period of time and with more media, a thicker pellicle can be
produced. The pellicles produced for this research project had a thickness of 2 - 3 mm
where there have been reports in the literature of pellicles of 2 - 4 cm thick, in cultures
maintained over 30 days [112]. As we will see during the rest of this chapter, starting
from a wet pellicle will increase the loading of silver - primarily due to an increase in
accessibility of the internal structure -

and correspondingly the antimicrobial

effectiveness of the end material.

4 .2 - Oxidation of the bacterial cellulose substrate
The second step, the oxidation of the BC, was the original focus of the research,
as it was assumed to provide a facile and effective method for tuning silver loading.
While this proved to be somewhat true, as we will see, the source of the cellulose, step
one, plays a more important role. The BC was oxidized using sodium metaperiodate
(NaIC>4 ) to obtain 2,3-dialdehyde cellulose (DAC). NaIC>4 breaks the C-2-C-3 bond of
the glucose residues resulting in the structure shown in Figure 4.4 [113].
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Figure 4.4: Oxidization Reaction

>
cr
c/>
o

&
o

CD

W a v e le n g th (c m '1)

Figure 4.5: FTIR spectrum of bacterial cellulose and oxidized cellulose

The oxidation was confirmed using fouricr transform infrared spectroscopy (FT-IR).
The low level of oxidation made it difficult to detect a change in the FT-IR spectra, and
so a sample of Biofill was oxidized for 20 hours as opposed to the single hour used for
sample preparation. The oxidized samples show peaks at 1735 cm' 1 and 880 cm"1 which
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correspond to the stretching of the free aldhyde and hemiacetal structure respectively. A
flattening of the OH peak is also observed [114].
4.2.1 - Quantify oxidation level: Biofill
The oxidation level was measured using the Cannizzaro reaction as described by
Pommerening et al. [108] This procedure provided a simple and repeatable method to
determine the number of aldehyde groups, expressed as a percentage of cellulose
monomers. An alternative method for determining the oxidation level involves using
optical absorbance to measure the initial periodate concentration and remaining
concentration after oxidation, to determine the percentage consumed. This method was
reported by Maekawa and Koshijima [115]. Both methods were compared by
RoyChowdhury and Kumar and showed to yield similar results under ideal conditions
[116], making using a redundant method moot. The optical absorbance method was
attempted, but ultimately failed to yield usable results, due most likely to the high ratio
of NaIC>4 to BC, with an expected change in NaIC>4 levels on the order of a fraction of a
percent. In other words, the sensitivity of that method was not great enough for this
application.
Table 4.1: Oxidation Level Biofill.

Sample (oxidation time)
15 minute
30 minute
60 minute

Oxidation L e v e l______
.52 ± .03%
.91 ± .03%
1.89 ±.08%

As can be seen by the small standard deviations, in Table 4.1, the oxidation reaction
produced highly repeatable results and the Cannizzaro method proved precise.

The

oxidation times of 15, 30 and 60 minutes were selected as a continuation of Guhados’s
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work; he had preformed the reaction on microcrystalline cellulose and BC produced in
shaken and agitated culture [107],

4.2.2 - Quantify oxidation level: lab made, wet pellicle
The oxidation procedure was adapted when the work shifted to using wet
pellicle. Wet pellicle is 99% water, with the remaining being BC. The high percentage
of water presented a challenge. For example during the oxidation step of the procedure,
a 15 minute oxidation time would not ensure that the NaI0 4 had diffused throughout the
sample, possibly preventing an even oxidation of the sample. Additionally, it would be
difficult to wash all the reagents from the sample afterwards.

To overcome these

challenges, the procedure was modified. Instead of using a set amount of oxidizing
agent and varying the reaction time, the reaction time was kept constant and the
oxidizing agent was varied. A time point of 24 hours was selected, and the molar ratio
of the oxidizing agent to BC was varied between .5:1, 1:1, 1.5:1, and 2:1. A sa reminder,
a fixed ratio of 13:1 was used for the dry pellicle samples, with the time points varied
from 15 minutes, 30 minutes, and 60 minutes. The resulting oxidation levels can be
seen in Table 4.2.
The oxidation level was determined using the same quantify procedure as the dry
pellicile (Biofill). The samples were dried before determining the oxidation levels.
Table 4,2: Oxidation Level Pellicle

Sample
Oxidation Level
5 N aI04: 1 BC
........................................... 2.6 ± .2 %
1 N aI04: 1 BC
4.2 ± .3 %
1.5 N aI04: 1 BC
5.8 ± .3 %
2 N a I0 4: 1 BC
6.8 ± .3 %
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The overall oxidation level was greater than that for the Biofill samples. This was done
intentionally to further increase the silver loading and antimicrobial properties.

The

upper limit was not arbitrary; 7% was not exceeded because it yielded a material that
cracked and flaked easily.

The loss of this structural integrity makes it unsuitable

consideration as a potential wound dressing.
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4.3 - Attachment of silver nanoparticles to the bacterial
cellulose substrate
The third step of linking the silver nanoparticles to the BC substrate can be
thought of in two discrete sub-steps: first, functionalizing the DAC in preparation for the
silver treatment; and second, the silver treatment.
The functionalization of the DAC is accomplished using thiosemicarbazide.
Thiosemicarbazide is a ligand, which has historically been used as a chelating agent. It
provides an anchor for the silver protienate. The thiolized DAC is seen in Figure 4.6.

nh 2

Figure 4.6: Cellulose with thiosemicarbazide

The conformation of the thiosemicarbazide and silver complex was explored by
Bonamartini et al. [117] They showed that there are two likely configurations, seen in
Figure 4.7 with M representing the metal ion. The first association is the only one that
could occur, given the bonding arrangement of the thiosemicarbazide and BC.

42

Figure 4,7: Thiosemicarbazide and metal ion bonding arraugeineut

The material presented in this thesis represents an extension of the work began
by Guhados in 2005. He was the first to used thiosemicarbazide with oxidized BC to
create a chelating polymer, although previously it has been combined with oxidized
plant cellulose to a similar end. Koshijima et al. had shown such a material has a high
affinity for silver and mercury, capturing 2.38 mMole/g cellulose and 3.12 mMole/g
cellulose respectively, with a lesser affinity for copper and cadmium [118].
There are two silver compounds used to produce the Ag-NPs. The first treatment
is with silver proteinate. Silver proteinate is proprietary silver protein complex that was
formally sold under the brand names of Argerol or Stillargol, and used to treat certain
eye and nose infections; its only modern use is in histological studies. The second form
o f silver used is ammoniacal silver, also known as Tollen’s reagent; it is sometimes used
in organic chemistry to distinguish between organic functional groups.
If divided differently the entire process can be thought of as a three-step process
(described by the main constituents): periodate - thiosemicarbazide - silver protienate
(PA-TSC-SP). This is how it is frequently portrayed in histology; where it is used as a
method for staining glycogen. The method is described in several textbooks [119] [120]
[121], and was widely used in the 1970s and 80s [122] [123]; but, it is difficult to find
reference to it in the literature during the 1990s or 2000s. This histological method
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resembles the one presented by Kuga and Brown in 1988 [124], in which they stained
the reducing end groups of BC fibers. Kuga and Brown did not oxidize the cellulose,
but instead demonstrated the orientation of BC fibrils in the larger fibers on nonoxidized samples. The process used was unique, as it did not use NaIO.4, but instead
relied on the reducing ends of the cellulose fibrils. Guhados also showed that the silver
maps to the sulphur locations using energy-dispersive x-ray spectroscopy, when the
above procedure was conducted on microcrystalline cellulose [107],

4.3.1 - X-ray diffraction

To properly evaluate the efficacy of the Ag-NP-BC dressing, it is important to
compare it to an established material that has a clinical history. In this case Acticoat was
selected, as it is widely held as the gold standard of silver dressing. To validate the
comparison, the nature of the silver particles must be examined and shown to be akin.
Acticoat is prepared through physical vapour deposition of silver on a
polyethylene substrate. As one can see from the diffraction peaks in Figure 4.8 the
silver on the BC has the same crystalline structure as those on Acticoat. The XRD
fingerprint corresponds to a face-centered cubic-structure [15]. These plots use a 10
point moving average to smooth some of the noise found in the data.
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Figure 4.8: XRD specta for nod silver-BC and Acticoat samples

4.3.2 - Scanning electron microscopy

The silver particle size was explored using SEM. An image of the silver loaded
Biofill (dry pellicle) is seen in Figure 4.9.

Multiple micrographs of several

independently made samples were taken, showing the repeatability, uniformity, and a
particles size that is seen in Figure 4.10. It should be noted that the resolution of the
micrographs was 4 nm/1 pixel. The histogram bin size were selected based on 4 pixels,
or 16 nanometers, this does not indicate a precision to last digit as the rules of significant
figures would normally suggest. It was difficult to obtain a more precise reading on the
particle size due to the resolution limitation of the SEM images. Transmission electron

microscopy could not be used due to the sample thickness. Regardless, these results do
show irrefutably that the majority of the particles fall between 32 and 64 nm.

Figure 4.9: S IM of silver loaded Biofill. 1.89 ± .08% oxidized.
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Particle Size (nm)
Figure 4.10: Silver particle size distribution on 1.89 ± .08% oxidized Biotlll sample. Based on figure 4.5 and
additional frames.

The lab made, wet pellicle samples were heavily coated with silver as can be
seen in Figure 4.11. While the coating looks particle based, it would be more apt to
describe it as BC coated an almost confluent layer of silver. This made particle size
determination impossible, hence no particle distribution is presented for the wet pellicle
based system.
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Figure 4.11: SKM of silver loaded on lab-made pellicle (6.8 ± .3 % oxidized) after drying at room temperature.

SEMs of Acticoat yield two different silver morphologies: the discrete particles
and grape-bunch types of silver as seen in A and B of Figure 4.12 respectively. The
discrete particles have a particles size falling primarily between 32 and 64 nm (Figure
4.13), while the clusters have an estimated size of between 200 and 500 nm, with knobs
of between 50 and 150 nm.

Both images have been taken from the same piece of

Acticoat, calling into question the consistency of the manufacturing process.
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Figure 4.12: SEMs of two different locations on Acticoat, demonstrate two different particles morphologies.
Scale bar applies to both A and B.

300

Particle Size (nm)
Figure 4.13: Silver particle size distribution from Acticoat Based on Figure 4. J2A and additional frames.
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4.3.4 - Silver loading: Biofill

It was hypothesized that the silver loading levels could be adjusted by changing
the oxidation level, fulfilling the criteria for making a tunable material.

Oxidation

weakens the material, therefore narrowing the range of workable oxidation levels;
although sufficient range was left to show a linear relationship between the loading of
silver and the oxidation level - this is seen in Figure 4.14. The linear relationship proves
the chemical association between the oxidation level and silver; further confirming what
was discussed in section 4.2.

The Y-intercept of the slope is the point that represents

non-oxidized BC (this was experimentally determined); this shows that there is both
silver associated with non-oxidized BC and that it is present in a proportionally large
amount.

Oneway ANOVA tests (p < .05) were preformed on the measurements

presented in Figure 4.14, the populations were statistically different in both the Y and X
directions, with the corresponding Tukey test showing that the points in the Y direction
are not statistically different from adjacent points.
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Figure 4.14: Oxidation of Biofill versus silver loading.

Having such a large amount of silver associated with the unoxidized BC,
suggests two possible associations. It could be silver bound to the reducing end groups
of the cellulose fibrils. As previously mentioned the silver binding process without the
oxidation step mimics the procedure that Kuga et al., use for labeling the reducing end
groups of BC [124], thus indicating that some of the silver is bound in a similar manner.
Or it could be unbound silver that has remained after the rinsing steps; while the samples
are rinsed after both the silver loading steps, the rinsing is gentle. It is possible that not
all the loose silver is removed during the rinses.

In one possible scenario, silver

protienate not removed during the rinsing is enhanced with ammoniacal silver in the
next step, creating unbound Ag-NPs caught in the Biofill mesh.
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If we compare the loaded silver with the silver that is released after 96 hours
from the sample (Figure 4.15), we see that the released silver is independent of the
loading level. The silver release seems to be primarily a function of sample mass, as
opposed to the original hypothesis that it would depend on silver loading levels although additional experimentation would be need to confirm this. In other words the
silver available for release is constant between samples, indicating the silver loading
does not affect silver available for release.

4.3.5 - Silver loading: Lab-made, wet pellicle

In Figure 4.15 the silver loading is expressed as a function of oxidation level, for
the lab made pellicle and compared to the data from Figure 4.14. It should be noted that
there is a much higher loading of silver. This can be explained once again by the 3D
structure of the wet pellicle, in which the internal structure is more accessible and
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available for silver deposition. When comparing the loading levels in the unoxidized
Biofill and wet pellicle samples - this high level of loading in the unoxidation would
suggest access to the internal structure makes a large difference. A portion of the silver
is bound to the reducing end groups of the cellulose fibrils; in a 3D environment these
end groups are more accessible and therefore can bind more silver, compared to the
essentially 2D Biofill.

Figure 4.16: Oxidation of lab made, wet pellicle versus silver loading (also including data from Figure 4.14)

Oneway ANOVA tests (p < .05) were preformed on the silver loading
measurements (Figure 4.16) showing that the population means are statistically different
in both the Y and X directions, with a corresponding Tukey test showing the points are
not statistically different to adjacent points in the Y direction.
Like previously discussed the linear relationship between the silver loading and
the oxidation level is an indication of the association between the aldehyde groups and
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the silver. There is a difference in the slopes of the lines, with the lab-made pellicle
expressing a less steep slope.

The reasons for this are not clear.

One possible

explanation is that the oxidation loosens the fibers of the Biofill, increasing the surface
area for silver binding. This would not have such a large material impact on lab-made
cellulose, because so much surface area is already exposed.
Similar to the case of the Biofill (dry pellicle), the amount of silver released over
a 96 hour period from the wet pellicle preparation is independent of silver loading levels
as seen in Figure 4.17. This reinforces the idea that silver release is a function of total
sample mass, suggesting that there are two species of silver present, bound silver and
unbound silver. The bound silver is responsible for the change in silver loading levels
with the oxidation level, and the unbound silver is responsible for the silver release. The
unbound silver would simply be a function of sample mass, much like the silver release.
Further experimentation would be required to confirm this. The entire baseline silver
loading is not necessarily unbound, like discussed, part could be bound to the reducing
end groups of the cellulose fibrils. This idea is reinforced when examining the silver
loading for 0% oxidation sample, showing that only about half of the loaded silver is
released.
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Oxidation Level (%)
Figure 4.17: Wet pellicle silver loading versus silver release after 96 hours.

4.3.6 - Silver loading by area

An alternative and practical way to look at the prepared samples is silver loading
by area. This provides the ability to compare the samples to the loading in Acticoat and
gives an idea of the dose that will be delivered to a wound and to the agar in the
antimicrobial tests. It should be noted that there is a difference in the thickness of the
lab-made cellulose and the Biofill prepared samples. The wet pellicle is 60±10 pm after
drying compared to the Biofill of 40±10 pm. This information is presented in Figure
4.18. Acticoat are the heaviest loaded samples.

Silver Loading (mg/cm2)

56

Figure 4.18: Silver loading by area. The biofill samples are labeled according how long they were oxidized for,
and the lab-made, wet pellicle are labeled according to the ratio of oxidizing agent to cellulose.
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4 .4 - Silver release
The material’s design is based on the supposition that binding the silver to the
substrate will create a better controlled release of the silver, increasing the longevity of
the antimicrobial properties and reducing tissue staining. To determine the longevity of
the dressing, it is important to derive a release profile for the silver.
4.4.1 - Silver release from dry pellicle (Biofill)

The traditional manner in displaying release curves is to show the mass released
over the total mass available for release. This is not the case with Figure 4.19, in which
the mass of silver released is shown as a fraction of the total silver on the compound.
Displaying the graph with the silver release as a percentage of total loaded silver,
conveys more information. For example as can be seen from the sample oxidized for 15
minutes, that silver release seems to level off at a level around 12 %. This suggests a
level of about 12 % of the loaded silver is available for release, information that could
not have been ascertained otherwise.
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Figure 4.19: Biofill release profile

The data presented in Figure 4.19 might suggest that the 15 minute oxidized sample
release more silver that the 60 minute oxidized sample, which is only partially true. The
release presented in the graph is a function of a fraction of the total silver, and the 15
minute oxidized sample has less silver loaded than the 60 minute sample, therefore the
fractional released is larger.

4.4.2- Lab-made, wet pellicle release

The curves for the samples prepared from the lab made, wet pellicle are similar to the
curves seen with samples prepared from Biofill. Figure 4.20 shows the release of silver
as a portion of total silver loading, and it is apparent that the samples with lower levels
of silver loading release a proportionally larger amount of silver.

The results for
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Acticoat are shown for comparison. It should be noted that Acticoat is 13 ± .4 % silver
by mass, and is tripled layered.

Figure 4.20: Release profile lab-made, wet pellicle

4.4.3 - Silver release mechanism
There are several possible modes of release. For example, when Acticoat is
placed in water the silver can be seen simply falling off the polyethylene substrate as a
fine black powder - this type of release may also be present in the BC based dressing
although does not occur in observable levels.

As previously discussed there is the

potential for unbound silver to be present in the material, and could influence the silver
release profile.
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Additionally, it should be noted that the total silver released is a percentage of
the total loaded silver. This is best explained by suggesting the largest component of the
released silver is unbound silver - which would be independent of the loading level, and
instead be a function of substrate mass. But, the simple letting go of the unbound silver
is not necessarily the only mode of silver release. The original design was based on the
premise that nanosilver dissolves into Ag+ and Ag° clusters (defined as a grouping of 8
or more atoms) as described by Fan and Bard. [125]. Hoskin et al. postulate that it is the
oxidation of the silver in an aqueous environment that contributes to this break down
with dissolved oxygen playing a role [126], as seen in the following mechanism:

0 2(aq) + 4H+(aq) + 4Ag°(s)

4Ag+(aq)+2H20(l)

Fan and Bard explore the release of silver from an Acticoat like material, as it relates to
silver clusters and silver ions in a 1 M NaC 1 0 4 solution. A limitation of the study
conducted for this project is that only total silver release is studied, without making the
distinction between Ag-NPs, Ag° clusters and Ag+ ions. But, it is safe to assume, silver
release can be summarized as having three distinct types of silver - Ag-NPs, ionic silver
and silver clusters.
Silver levels were measured using Atomic Absorption Spectrophotometry, which
had the advantages of simplicity and availability, allowing for the testing of a multitude
of samples; but had the disadvantage of poor sensitivity, measuring only to.5 ppm. In
Gray’s PhD thesis, conducted on the nanosilver linked polyurethane substrate, she
attempted to use AAS, but was ultimately unsuccessful due to its lack of sensitivity
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[127], She was only able to evince through indirect methods (antimicrobial results) that
silver was released.
The other disadvantage of AAS is its inability to handle highly ionic solutions the silver signal was lost when testing the release in phosphate buffered solution. In the
past other groups have investigated the release of silver into several ionic solutions
including: alpha-medium, PBS(-), calf serum, .9% NaCl, artificial saliva, 1.2 mass% 1cysteine, 1 mass% lactic acid, .01 mass% HC1, and simulated body fluid [128] [129] using inductively couple plasma mass spectrometry (ICP-MS). The release of silver into
an ionic solution or the wound environment raises interesting questions.

The silver

release, if in ionic form would quickly bind to negative ions in solution, for example
chlorine, forming biologically inactive silver-chloride.

In the case of Acticoat, the

recommended application procedure in clinical settings requires soaking the dressing in
distilled water - as oppose to the standard saline. Whether this step is superfluous or
not, as the dressing is then applied to the normally strongly ionic concentration of a
wound’s exudate, is an excellent question. The answer, unfortunately, is still elusive.
Despite this, the release of silver into de-ionised water has been investigated in the
literature with proven silver systems [4],

!t
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4.5 - Antimicrobial properties
The microbial test preformed on the samples was an adapted disk diffusion test.
The genuine disk diffusion test is a qualitative clinical procedure used to determine the
susceptibility of bacteria to a specific antibiotic.

The genuine test is preformed by

inoculating a Mueller Hinton agar Petri dish with an aliquot of bacteria and placing a
standardized sized disk soaked in a specific antibiotic on the agar.

The antibiotic

diffuses out of the disk preventing the bacteria from growing in a halo like area around
the disk. The size of this halo is dependent on several factors; including how susceptible
the bacteria is to the antibiotic, how well the antibiotic diffuses through the agar,
whether the antibiotic reacts with the agar, and how well the bacteria grows on the agar.
In a clinical setting the test results are compared to a set of standards either developed in
lab or provided by the Clinical and Laboratory Standards Institute (CLSI) - and a
dichotomous result is given: susceptible or resistant.
While CLSI publishes the standards for a wide range of antibiotics, they have yet
(as of 2008) to published results for any test involving silver compounds. But, the test
remains widely used in the literature to examine the efficacy of silver compounds,
although frequently interpreted to offer more qualitative results.

Several researchers

have raised concerns, with Falcone and Spadaro stating that the inhibition zone from
silver materials

. .are complex and appear to be self-limited in size due to diffusion and

competing binding process.” [13] Silver ions react readily with the agar, so much so that
in the case of silver nitrate loaded BC, the agar beneath the cellulose sample turns white
with what is assumed to be silver chloride.

With other silver species no noticeable

change in the colour of the agar is observed, but it is highly likely these competing
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binding processes are still at work. Additionally, the clear zone is established (although
not observable) within the first 3 to 6 hours after placing the sample on the dish [109],
In this short time, silver nanoparticles would diffuse to a lesser extent than smaller
antibiotics, creating a clearzone that is comparatively smaller.
Modifying the test has mitigated some of these problems. First the inclusion of
an Ag-NPs ‘standard’ dressing, in the form of Acticoat, was used. This reduces the
requirement for a comparison to the CLSI standards, as Acticoat becomes the measuring
stick, having a history as an effective silver dressing.

As discussed earlier, an

examination of Acticoat indicates that the Ag-NPs are of approximately the same nature
as those present in the BC prepared sample. And while there is little to be done about
the competing binding processes that Falcone and Spadaro alluded to, these will at least
be equal in both cases. Additionally, to offset the limitations of the test, it is expanded
to a multiday test by following the procedure established by White et al., and instead of
drawing conclusions only on the comparative efficacy of the material, information on
the longevity of the dressing can be discerned. In a 2005 paper by Callant-Behm et al.,
published explicitly as an indepth analysis of the disk diffusion test versus a kill-kinetic
test for silver dressings, concludes that the White et al. method provides “...useful data
as to dressing longevity...” [130]
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4.5.1 - Disk diffusion test - Biofill
Table 4.3: Clear zone size - Bio fill prepared samples.

Sample
15 minute oxidized
30 minute oxidized
60 minute oxidized
Acticoat

Clear Zone:
E. coli
0 mm
0 mm
0 mm
1 - 2 mm

Clear Zone:
S. Aureus
.5-1.5 mm
.5-1.5 mm
.5-1.5 mm
1.5 -2.5 mm

The clearzone sizes are listed in Table 4.3. One should refer to the Methods section to
view how these were determined; the procedure is comparable to those published in the
scientific literature, but differs from that established by the Clinical and Laboratory
Standards Institute (CLSI). The numbers are presented as a range in part to indicate the
qualitative nature of the test, as opposed to a more quantitative test. Additionally, it
should be noted that while the E. coli and S. aureus results are displayed in the same
table they should not be compared, only numbers within a column should be compared.
This is due to the inclination of E. coli to Mueller Hington agar (the standard agar used
for this test). In other words, E. coli grows better that S. aureus on Mueller Hington
agar, making the clear zones smaller, or in this case non-existent.

Table 4.4: Days of observable clear zone - Biofill

Sample
15 minute oxidized
30 minute oxidized
60 minute oxidized
Acticoat

Days of observable clear zone (5. a u reu s)
1 day
1 day
1 day
6 days

Table 4.4 shows the longevity of the samples.

Both tables show that there is little

difference between the efficacies and the longevities of the different oxidation levels.
(
I
♦
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This leads to the conclusion that longevity is based on silver release and is independent
of silver loading.

The longevity was also much less than Acticoat was the watershed

result that eventually led to the revaluation of initial substrate and following that, the use
of wet pellicle.

4.5.2 - Disk diffusion test - wet pellicle

The antimicrobial tests conducted on the lab-made cellulose are modified dearzone tests, the same as those conducted on the Biofill prepared samples. The results
were significantly better than the Biofill.

One can see in Table 4.5 that the clear zones

are significantly larger than those seen with the Biofill samples. The S. aureus clear
zones are larger than those of the E. coli, due to the fact that S. aureus does not grow as
well as the E. coli on the agar used. As discussed in the last section, more silver is
present and more silver is released in lab-made, wet pellicle samples than the Biofill
prepared samples, this directly results in the larger clear zone.
Like before, the results again are given as a range, indicating the uncertainty in
measuring the clearzone size.

While some slight variation in the S. aureus

measurements, the conclusion is that all sample preparations have essentially similar
efficacy. This corresponded to the release kinetics, which show antimicrobial efficacy is
dependant on silver release, and not silver loading - this is not a totally unexpected
result.
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Table 4.5: Clear zone sizes - lab-made pellicle samples.

Sample
.5 N aI04: 1 BC
1 N aI04: 1 BC
1.5 N aI04: 1 BC
2 N aI04: 1 BC
Acticoat

Clear Zone:
E. coli
1 - 2 mm
1 - 2 mm
1 - 2 mm
1 - 2 mm
1 - 2 mm

Clear Zone:
S. aureus
1.5 -2.5 mm
1.5 - 2.5 mm
1 -2.5 mm
1 - 2 mm
1.5 - 2.5 mm

The longevity of the sample is displayed in Table 4.6. But, once again there was
little difference between oxidation levels, suggesting that like antimicrobial efficacy and
longevity is dependant on silver release.
The results do show that samples remain active for five days having a similar
longevity as Acticoat. If we compare these results to the area density of silver (Figure
4.18) we see that these results are accomplished about one third of silver per square
centimeter as Acticoat, as the case with wet pellicle cellulose oxidized with a ratio .5:1
(oxidizer to cellulose).

This initial loading difference in silver loading does not

necessarily translate into a difference in dose, with the total dose per cm of Acticoat
falling within the range of total doses for the wet pellicle samples. The pellicle sample
has the added advantage of a closer adhesion of the material to the agar, which would
translate into the real world application with a closer adhesion to the wound bed.

Table 4.6: Days of observable clear zone - lab-made pellicle samples

Sample
.5 N aI04: 1 BC
1 N aI04: 1 BC
1.5 N aI04: 1 BC
2 N aI04: 1 BC
Acticoat

of
observable
Days of observable of Days
clearzone: S. aureus
clearzone: E. coli
5 days
5 days
5 days
5 days
5 days
5 days
5 days
5 days
6 days
5 days
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4.6 - Alternatives
The results lead to the conclusion that the initial premise of binding silver to the
BC substrate maybe unnecessary, and should be reevaluated.

An alternative is the

creation Ag-NPs in the interior mesh like structure of the wet pellicle. There are several
manners in which to create silver nanoparticles and several of these were explored.
These included using silver nitrate and an autoclave or the reducing agent sodium
borohydride. More information can be found on these in Appendix A. While there is
substantially more work to be done on these systems to appropriately evaluate their
efficacy, the groundwork has been laid.
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Chapter 5 - Conclusion and Future Design
Considerations
The research outlined in this thesis explores variations on one approach of
combining silver and bacterial cellulose, for the production of an antimicrobial material
that can be used as a biomedical biomaterial. The process yields a novel material, with
nanocrystalline silver bound to the surface. It was expected that the bounded Ag-NPs
would release silver in a bioactive form and provide an antimicrobial effect, while this
may have occurred it did not do so in distinguishable levels. Instead unbound silver
caught in the BC mesh was released and created the antimicrobial effect. This leads to
two possible thought pathways: one redesign the material to focus on unbound Ag-NPs,
several methods are described in Appendix A for doing this; or examine the
effectiveness of the material in such settings where the release of silver is not required.
Surgical gloves would be a good example of a device where bound silver could
potentially prevent bacteria from sitting on the surface of the glove, decreasing the
chance of spreading infection.

The effectiveness of non-released or non-releasable

silver preventing the buildup of bacterial is not established in the literature, and is
suggested here merely as a hypothesis.

One consideration in the development of this biomaterial is the type of BC used.
Two types were examined in this thesis, Biofill and lab-made wet cellulose (reacted wet,
used dry); a third exists. Guhados originally developed the silver loading process on
loose BC fibers. The fibers were produced in shaken and agitated cultures, methods that
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have several distinct advantages and disadvantages. One advantage is the potential for
scale up, but as stated in the Literature Review this promise has yet to be realized.
Another advantage is the direct use of loose fibers in nanocomposites, with the
corresponding disadvantage being to use the loose fibers for a wound dressing they
would need to be cast in a film. The main disadvantage is the added complexity in
production - there is difficulty with pellicle to ensure all reagents are rinsed from the
cellulose after each step - this difficulty is multiplied with the use of loose fibers. Loose
fibers must be washed in a centrifuge; it would be a time consuming and difficult task to
ensure all the reagents were rinsed from the BC. Not all of the color is removed from
the cellulose after even a dozen washes, suggesting at least some contaminants remain;
purity is an important characteristic for biomedical materials.

This leads to the

conclusion BC should be produced in pellicle form, except when used in a composite.
The data presented in the thesis also leads to the conclusion that the silver loading
should be conducted on wet 3D pellicle instead of dry pellicle.

The commercial future of a material based on the three step process explored in
this thesis is questionable. Several criteria must be examined before proceeding towards
a path of commercialization. First, the cost of silver proteinate is prohibitive. Second,
designing a scaled production line would be difficult, especially with rinsing between
steps. Third, biocompatibility test need to be conducted; the outcome of which are not
assured. While BC is biocompatible, the biocompatibility of the other constituents are
either not known or not good. Silver proteinate has had a medical role in the past, and
some

grades

have

been

sold

under

the

brand

Argerol

for

medical

use.
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Thiosemicarbazide is both allergenic and toxic, with an oral dosage for a rat of 9 mg/kg,
with a specific warning against irritation to skin; whether binding it to BC mitigates this
toxicity is unknown. Also, if there is any remaining ammoniacal silver, this too could
cause biocompatibility issues.
Some aspects of the design still need to be examined. As mentioned during the
discussion, the oxidation process weakens the material; the ideal strength and flexibility
of the material depends on the application, but should be qualitatively studied.
Additionally, one of the important benefits of BC for a wound dressing application is its
transparency; this is compromised by silver loading. Where the ideal balance between
silver loading and transparency lies needs to be determined and the oxidation level
adjusted to optimize for that criteria. Another feature not tested for was the potential for
staining of the skin and wound tissue, any material that leave silver behind will create
localized discoloration. In other words, staining should be expected.
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Appendix A - Alternative Methods
There is compelling evidence presented in the body of this thesis indicating that
the antimicrobial efficacy of the discussed material is due to unbound Ag-NPs. There
are several possible procedures for developing simpler systems, they rely on the idea of
creating silver particle in situ - in the unwoven fiber mat of either Biofill or lab made,
wet pellicle - instead of binding the Ag-NPs to the BC fibers. A few potential methods
were explored, they have been evaluated using some of the techniques already discussed
in the body of this thesis, but none has been subjectted to the full battery of tests.
' 2 r 5 ,t

A.1 Autoclaved silver
One of the simplest methods for creating a nanosilver dressing is using the steam
and pressure of an autoclave. This procedure has been explored using cellulose cotton
by Vigneshwaran et al. [131]. That research group created an Ag-NP cotton material by
placing a cotton sample in a solution of silver nitrate and autoclaving it. This method
was adapted for use with BC, and provides a promising method for creating the novel
nanomaterial. The exact mechanism that creates the Ag-NPs is unclear, Vigneshwaran
hypothesize that it was starches in the cotton that reduced the silver, these would not be
present in the BC, therefore eliminating it as a possibility.
The procedure has one distinct advantage - it uses only compounds that are
already used in the treatment of wounds, silver nitrate and BC; no other chemical
treatments are required. Additionally, the final product remains flexible and strong,
without the degradation of strength that accompanies oxidation. Any unreduced silver
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will remain as silver nitrate, which already has antimicrobial properties.

During

manufacturing, the combination of the autoclaving step for production could be
combined with the sterilization step reducing overall costs.

A.1.1 - Autoclaved silver: Methods
Biofill was placed in a solution of AgN0 3 of concentration of .1 M, and left for
15 minutes. The Biofill in solution was placed in the autoclave, and run on a 15 minute
wet cycle. The cycle reached a temperature of 121° C and a pressure of 15 psi. The
samples were removed from the autoclave and solution, and dried in a convection oven
at room temperature.

Optical absorbance for the silver loaded BC samples was determined using a
Beckman Coulter DU 520 UV-Vis Spectrophotometer.

They were backgrounded

against Biofill.

For additional characterisation techinques please see Chapter 3: Methods.

A.1.2 - Autoclaved silver: results and discussion
No scanning electron microscopy was performed on the samples. Instead optical
absorbance was used to confirm the presence of Ag-NPs.

Optical absorbance is

frequently used for this purpose with a peak at 450 nm indicating the presence [132] of
Ag-NPs. This peak is seen in Figure A.l and therefore confirms the presence of AgNPs.

XRD was conducted on the samples, but no peaks corresponding to
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nanocrystalline silver were observed (Figure A.2); this could be because there is no
crystalline silver, or could be a result of a level that is below the detectible range. Table
A. 1 shows that the amount of Ag-NPs makes up a smaller proportion of the total sample
weight than the materials discussed in the body of the thesis; the silver loading for a 100
mM autoclaved sample is 5.1% silver compared to 5.5% silver for the unoxidized Biofill
sample. It should be noted that the method described in the body of this thesis places the
samples in two solutions of silver; the first having a significant silver concentration and
second has a silver nitrate concentration of about 70 mM prior to adding the ammonia
hydroxide. Summing these two treatments would put the amount of silver to prepare
those samples at a higher level than the level of silver used to prepare the autoclaved
samples.
The results of the antimicrobial tests can be seen in Table A.2. The antimicrobial
test showed that there was an antimicrobial effect for the heavier loaded sample.

Absorbance
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Wavelength (nm)

Figure A.1: Autoclaved samples - optical absorbance. Background plain BC.
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Figure A.2: Autoclaved samples - XRD

Table A.1: Autoclaved samples - silver density

Sample

Silver Density (w/w%)

100 mM
10 mM

5.1 ±.15
1.8 ±.37

Table A.2: Autoclaved sam ples- antimicrobial size of clearzone

Sample
100 mM
10 mM

Clear Zone:

Clear Zone:

E. c o li

S. A u r e u s

0 - .5 mm
0 mm

.5-1.5 mm
0 mm
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Table A.3: Autoclaved samples - antimicrobial longevity

Sample
100 mM
10 mM

Days of observable of Days
of
observable
clearzone: E. c o l i ___ clearzone: S. a u reu s
1 days
2 days
_____ 0 days
0 days

A.2 - Sodium borohydride reduced
Sodium borohydride (NaBHU) is a strong reducing agent that has been used
throughout the literature to reduce silver nitrate to Ag-NPs. If combined with BC, it can
be an easy method for creating an Ag-NP material.

Maneerung et al. describe this

method in a paper published in April 2008, as one can see from the date on the SEMs I
independently developed the same method [133]. The major concern with this method
is removing the remaining sodium borohydride and/or products of the reduction from the
BC. Maneering et al. washes the BC thoroughly to mitigate this concern, but this is not
a perfect solution. Washing probably removes some of the silver, creating inefficiency
in the process and does not ensure all the sodium borohydride is removed.

A.2.1 - Sodium borohydride reduced: Method
Biofill samples were soaked in silver nitrate solutions of 100 mM and 10 mM of
solution for 15 minutes. The samples were removed from the silver solution and placed
in a solution of 100 mM of sodium borohydride. They were left for 5 minutes, and then
rinsed. The were dried in a convection oven at room temperature.
For characterisation techinque please see Chapter 3: Methods.
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A.2.2 - Sodium borohydride reduced: Results and discussion
These samples have the same efficacy as the autoclaved perpared samples, but
with less silver.

The lower silver level could be the result of a few factors, the

autoclaved samples were kept in the silver solutions for a longer period of time (15
minutes, plus the time in the autoclave), this could of allowed for a more silver to soak
in and/or more silver to form Ag-NPs; but, more likely the reduced silver content is a
result of rinsing the samples.

This is a simple and effective system, but with the

drawback of dealing with the products of the silver nitrate - sodium borohydride
reduction.
The optical absorbance was taken for the 100 mM sample, and a peak as 450 nm is
observed (Figure A.3). Like with the autoclaved sample this shows the presence of AgNPs.

This is further confirmed with SEMs. Figure A.4 shows Ag-NPs on the BC

substrate. The Ag-NPs are small on the order of 20 - 50 nm.

Absorbance

Wavelength (nm)
Figure À.3: Optical spectra for sodium borohydride prepared samples. Background plain BC.
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Figure A.4: SEM of sodium borohydride prepared samples

Table A.4: Silver Density on Sodium Boroliyride prepared samples

Sample
100 rnM
10 mM

Silver Density (w/w%)
2.4 ±.5
1.1 ±.5

Table A.5: Silver nitrate - antimicrobial size of ciearzone

Sample
100 mM
10 mM

Clear Zone:
E. coli
0 - .5 mm
0 mm

Clear Zone:
S. Aureus
.5-1.5 mm
0 mm
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Table A.6: Silver nitrate - antimicrobial longevity

Sample
100 mM
10 mM

Days of observable of Days
of
observable
clearzone: E. coli
clearzone: S. aureus
1 days
2 days
0 days
0 days

A.3 - Silver Nitrate
The simplest method to create a BC silver loaded dressing is to soak a piece of
BC in silver nitrate, and do nothing else. This would not create an Ag-NP material, but
could add some value to the standard BC dressing.

It has the advantages of being

simple, and having both constituents already used in wound care would allow for an
expedited approval process.

A secondary objective of testing these samples was to

establish controls for the above methods. The silver loading was not measured.

A.3.1 - Silver nitrate: Method
Biofill samples were placed in 100 and 10 mM AgNC>3 solutions, and left for 15
minutes. The samples were removed and air-dried. Antimicrobial tests were conducted
in triplicate.

A.2.2 - Silver nitrate: Results and discussion
The results show that just adding silver nitrate to BC creates an antimicrobial
material; this is an obvious result.

The results also show that both the sodium

borohydride and autoclaved samples are slightly better when it comes to antimicrobial
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efficacy. Further testing will be required to fully explore the difference in activity for
the autoclaved and silver nitrate samples. The results are about the same as the results
seen in the body of the thesis for Biofill prepared samples - but as previously stated
these samples are easier to prepare, and probably more likely to pass regulatory hurdles.

Table A.7: Silver nitrate - antimicrobial size of clearzone.

Sample
100 mM
10 mM

Clear Zone:
E. coli
0 - .5mm
0 mm

Clear Zone:
S. aureus
0 - 1 mm
0 mm

Table A.8: Silver nitrate-- antimicrobial longevity tests.

Sample
100 mM
10 mM

Days of observable of Days
of
observable
clearzone: E. coli
clearzone: S. aureus
1 day
1 day
0 days
0 days

